INS and Alzheimer disease: Brain insulin resistance, defined as deficient insulin effect transmission due to reduced insulin receptor (IR) density or impaired cellular signaling pathway, has also been described in the context of AD progression, existing independently of peripheral insulin sensitivity [40,41].